MEDIVIS
Medivis is a New York-based medical technology company that builds FDA-cleared augmented reality surgical visualization and navigation software (SurgicalAR) for hospitals and surgeons, with an adjacent AR-based medical education platform (AnatomyX) deployed across medical schools.
- Company typePrivate
- Founded2016
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What MEDIVIS does
Medivis is a New York-based medical technology company founded in 2016 by neurosurgeon Dr. Osamah Choudhry and radiologist Dr. Christopher Morley. It develops an augmented reality surgical visualization and navigation platform, branded SurgicalAR, that converts 2D cross-sectional medical imaging (CT, MRI) into 3D holographic overlays displayed via head-mounted displays during surgery. The platform supports FDA-cleared Spine Navigation (cleared April 2025) and Cranial Navigation (cleared December 2025, the world's first AR system cleared for intraoperative guidance in cranial neurosurgery), as well as research-stage Prostate Navigation. Adjacent offerings include the AnatomyX medical education platform (deployed across 40+ medical schools including Yale, Emory, and Rush), an Ultrasound Add-On integrated with Clarius wireless probes, and a three-tier hardware line (Medivis PRO for operating rooms, CORE for ICUs and clinics, and VIEWER for office-based pre-surgical planning). Underlying technology includes proprietary computer vision algorithms, automatic and prompt-based AI segmentation, multi-method registration (4 to 4000+ point-pairs), infrared instrument tracking, and an upcoming AI agent ('Maia').
The company sells to enterprise healthcare customers through a direct sales motion, primarily large hospital systems (UPMC, Providence Swedish, Lenox Hill/Northwell, MD Anderson, University of Miami) and the Veterans Health Administration. Revenue is generated through quote-based annual software subscriptions for SurgicalAR and AnatomyX, hardware sales of proprietary workstations and HoloLens devices, and professional services for implementation and training. Deployments to date include 17+ medical centers and 40+ hospitals and medical schools nationwide, with 2,000+ surgeries performed on SurgicalAR and 2,000+ active users on AnatomyX.
Medivis has raised approximately $22-25 million in venture funding across a 2019 seed round led by Initialized Capital, a 2020 round, and a 2023 Series A led by Thrive Capital with participation from Mayo Clinic, Initialized Capital, and individual investors including Bob Iger, Kevin Durant, Dr. Robert Spetzler, Hugo Barra, and Coalition Operators. Strategic technology partners include Microsoft (HoloLens co-marketing), Clarius (ultrasound integration), and Verizon (5G-enabled VA hospital deployments). The company holds 46 patents granted and pending and has received TIME Best Inventions 2023, Fast Company Most Innovative Companies 2024, and Edison Award Gold Finalist 2024 recognition.
MEDIVIS firmographics
Firmographics- Name
- MEDIVIS
- Legal name
- Medivis, Inc
- Website
- https://medivis.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medivis is a New York-based medical technology company that builds FDA-cleared augmented reality surgical visualization and navigation software (SurgicalAR) for hospitals and surgeons, with an adjacent AR-based medical education platform (AnatomyX) deployed across medical schools.
- Ownership category
- akta.pro rank
MEDIVIS industry classification
Industry- Product category
- Surgical Navigation Software
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
- akta.pro secondary industries
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD), Medical Imaging AI (HDAAAEAH)
Keywords
Where MEDIVIS is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MEDIVIS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- SurgicalAR Software Subscription: Enterprise software licensing model for the SurgicalAR platform, sold to hospitals and surgical centers. Subscription-based access to the AR surgical visualization and navigation software with annual billing.
- AnatomyX Subscription: Annual subscription model for the AnatomyX medical education platform. Grants full access to the platform and comprehensive suite of features including 3D AR anatomy models and multi-user sessions.
- Hardware Sales: Sale of AR hardware configurations (Medivis PRO, Medivis CORE, Medivis VIEWER) and optional Microsoft HoloLens 2 headsets. Enterprise hardware procurement alongside software deployment.
- Professional Services: Implementation, training, and support services for enterprise deployments. Contact forms indicate dedicated channels for clinical research, partnership, and distributor inquiries.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | AnatomyX Annual Subscription |
Distribution channels1 record
Marketing channels7 records
MEDIVIS product offering
Product offeringCore offering
Medivis develops and sells the FDA-cleared SurgicalAR augmented reality platform, which transforms 2D medical imaging (CTs and MRIs) into high-fidelity 3D holographic visualizations overlaid on patients during surgery. The platform powers specialty navigation modules for spine, cranial, and prostate procedures, and is paired with AnatomyX, an AR-based medical anatomy education platform for institutions. The company also sells Medivis PRO, CORE, and VIEWER hardware configurations and offers implementation, training, and support services to enterprise healthcare customers.
Product overview
Medivis is a surgical intelligence company offering a platform-plus-modules architecture centered around its FDA-cleared SurgicalAR platform for 3D surgical visualization. The core SurgicalAR platform integrates with hospital PACS systems and supports multiple navigation products including Spine Navigation (FDA cleared), Cranial Navigation (FDA cleared, world's first AR system for cranial neurosurgery), and Prostate Navigation (FDA clearance pending). Additional products include AnatomyX for AR-based medical education and an Ultrasound Add-On for point-of-care ultrasound integration. The company leverages Microsoft HoloLens hardware and proprietary AI/ML capabilities including computer vision algorithms and automatic segmentation models.
Differentiator
Problem solved
Functional benefit
Brands
- SurgicalAR: The leading enterprise solution for 3D surgical visualization that transforms complex 2D cross-sectional imaging (CTs, MRIs) into high-fidelity 3D visualizations for surgical planning and navigation.
- AnatomyX
Products and services
- SurgicalAR The leading enterprise solution for 3D surgical visualization that transforms complex 2D cross-sectional imaging (CTs, MRIs) into high-fidelity 3D visualizations using augmented reality. FDA-cleared and CE-marked, it enables surgeons to view critical anatomy overlaid on patients during procedures. Sold to hospitals and surgical centers on an annual subscription.
- Spine Navigation FDA 510(k) cleared AR navigation platform designed for open and minimally invasive spine surgery. Combines proprietary computer vision algorithms, AI segmentation, real-time data analysis, and advanced image processing to deliver precise context-aware insights throughout the surgical workflow for neurosurgeons and orthopedic surgeons.
- Cranial Navigation FDA 510(k) cleared AR platform for cranial neurosurgery and the world's first AR system cleared for intraoperative guidance in cranial neurosurgery. Enables real-time spatial mapping of patient imaging within the operative field for EVDs, subdural evacuations, and craniotomies, with portable design extending image-guided precision to ICUs.
- Prostate Navigation Research-only AR navigation platform designed for prostate biopsies and tumor ablations. FDA clearance pending; AR-guided surgery significantly improves outcomes with 52% lesion positivity vs 13% for standard care in robotic prostatectomy (RIDERS trial).
- AnatomyX Full-body 3D anatomy education platform with augmented reality for medical schools, universities, and residency programs. Features 5,000+ anatomy models, 8,000+ anatomical parts, 13,000+ assessments, multi-user shared sessions (up to 30 users), personalized quizzes, and custom prosections. Available on Microsoft HoloLens 2.
- Medivis PRO Hardware Hardware configuration for operating rooms featuring a minimal-footprint powerhouse with 27-inch touch monitor, 4K graphics, NVIDIA GPU, and hybrid sensor tracking for the SurgicalAR platform.
- Medivis CORE Hardware Portable workstation hardware configuration for ICUs and clinics with a 17-inch touch monitor designed for maximum maneuverability alongside the SurgicalAR platform.
- Medivis VIEWER Hardware Hardware configuration for office use providing immersive next-generation visualization to plan surgeries from anywhere using the SurgicalAR platform.
Quantifiable outcome
- EVD misplacement rates reduced through AR-guided visualization (estimated 30% misplacement rate with standard care vs significantly improved with Medivis Cranial Navigation)
- +4 more outcomes
Companies that use MEDIVIS
Customer profileNamed customers13 records
Segments3 records
Ideal customer profiles3 records
MEDIVIS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature9 records
MEDIVIS partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and flagship.
- MicrosoftcoreTechnology partnership as Microsoft technology partner. Medivis leverages Microsoft HoloLens technology for its SurgicalAR and AnatomyX platforms. Medivis showcased SurgicalAR at Microsoft booth #8300 at HIMSS 2019.
- Providence SwedishflagshipMajor medical center partnership for brain surgery and presurgical planning using Microsoft HoloLens 2. Providence Swedish is recognized as leading the world in brain surgeries with Medivis technology. Featured in Microsoft customer stories.
- UPMC (University of Pittsburgh Medical Center)flagshipLeading medical center partner using SurgicalAR for brain surgery and presurgical planning. Major deployment partner for Medivis technology.
- MD Anderson Cancer CenterflagshipLeading cancer center partner announced in Series A. Using Medivis technology for surgical planning.
- Northwell HealthflagshipMajor health system partner announced in Series A press release.
- Cincinnati Children's HospitalcorePediatric hospital partner announced in Series A press release.
- Veterans Health AdministrationflagshipExpanded partnership announced in Series A. Nation's largest integrated health system using Medivis technology for veteran healthcare. Partnership with Verizon and Microsoft for 5G-enabled hospitals.
- ClariuscorePartnership for wireless ultrasound probe integration. Clarius provides 2nd-generation curved, linear and endocavity probes that are fully integrated with SurgicalAR for point-of-care ultrasound visualization.
- Lenox Hill HospitalflagshipMajor medical center partner using SurgicalAR for neurosurgical applications.
- University of MiamicoreMedical center partner using Medivis products for surgical planning.
- VerizoncorePartnership for 5G-enabled hospitals for veterans. Verizon provides 5G infrastructure enabling advanced healthcare services.
Scale indicators8 records
Recent moves7 records
Expansion highlights7 records
MEDIVIS competitors and assessment
Company assessmentDirect peers
- Augmedics: Augmedics developed xvision, an AR headset-based spine navigation system. It is a direct competitor to Medivis's Spine Navigation platform, targeting similar orthopedic and neurosurgical spine procedures with FDA-cleared AR guidance.
- Surgical Theater: Surgical Theater provides VR/AR-based surgical planning and visualization for neurosurgery, with FDA clearance. It directly competes with Medivis on immersive visualization for surgical planning and patient engagement.
Broad incumbents
- Brainlab: Brainlab is a leading incumbent in surgical navigation, image-guided surgery, and operating room integration. It competes broadly with Medivis across neurosurgery and spine, with a far larger installed base and global distribution.
- Medtronic (StealthStation, Mazor): Medtronic offers the StealthStation surgical navigation system and Mazor spine robotics platform, both of which compete with Medivis in cranial and spine surgical navigation. As a large incumbent, it has the resources to add AR-based features over time.
- Stryker (Mako / Spine Division): Stryker operates in surgical navigation and robotics (Mako, acquired from MAKO Surgical, and spine hardware). It is a broad incumbent competitor in navigated spine and orthopedic surgery where Medivis's Spine Navigation is positioned.
- Philips (Azurion / Mixed Reality): Philips provides image-guided therapy and operating room visualization, including mixed-reality initiatives. As a broad incumbent in medical imaging and procedural suites, it competes at the ecosystem level with Medivis's SurgicalAR.
- Siemens Healthineers: Siemens Healthineers offers advanced imaging, surgical planning, and increasingly AR/AI visualization in interventional and surgical workflows. It is a broad incumbent whose visualization and imaging capabilities are adjacent to Medivis's SurgicalAR platform.
Emerging players
- Proprio Vision: Proprio is developing AR/AI-enabled surgical guidance for spine and neurosurgery, with an emerging platform using light-field and computer vision. It is an emerging AR-surgical-navigation peer focused on overlapping indications.
- FundamentalVR: FundamentalVR provides VR-based surgical simulation and training with haptic feedback. It is a partial competitor in the medical-education / surgical-training segment that overlaps with Medivis's AnatomyX platform.
- 7D Surgical (now part of Proprio): 7D Surgical developed machine-vision-based surgical navigation for spine and cranial procedures. It is an emerging player whose navigated-surgery focus overlaps with Medivis's core offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
MEDIVIS social profiles
Digital presenceMEDIVIS compliance and trust
Trust signalCompliance5 records
MEDIVIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
MEDIVIS leadership team
Management profileNumber of profiles
Profiles3 records
MEDIVIS funding detail
Funding detailFunding overview
Funding rounds3 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MEDIVIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MEDIVIS
What does MEDIVIS do?
Medivis develops and sells the FDA-cleared SurgicalAR augmented reality platform, which transforms 2D medical imaging (CTs and MRIs) into high-fidelity 3D holographic visualizations overlaid on patients during surgery. The platform powers specialty navigation modules for spine, cranial, and prostate procedures, and is paired with AnatomyX, an AR-based medical anatomy education platform for institutions. The company also sells Medivis PRO, CORE, and VIEWER hardware configurations and offers implementation, training, and support services to enterprise healthcare customers.
Is MEDIVIS a public or private company?
MEDIVIS is a private company. It is classified as venture growth investor backed and is currently operating.
When was MEDIVIS founded?
MEDIVIS was founded in 2016. It employs 11 to 50 people.
Where is MEDIVIS based?
MEDIVIS is headquartered in New York, United States, in the North America region.
How does MEDIVIS make money?
Four revenue lines are on record. SurgicalAR Software Subscription is the primary driver. The others are anatomyX Subscription, hardware Sales and professional Services.
Who are MEDIVIS's main competitors?
Direct peers on record are Augmedics and Surgical Theater. Broad incumbents are Brainlab, Medtronic (StealthStation, Mazor), Stryker (Mako / Spine Division), Philips (Azurion / Mixed Reality) and Siemens Healthineers. Emerging players are Proprio Vision, FundamentalVR and 7D Surgical (now part of Proprio).
Does MEDIVIS have an API?
No public API is recorded for MEDIVIS.
What industry is MEDIVIS in?
MEDIVIS's product category is Surgical Navigation Software. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms. Its NAICS code is 33451 and its SIC code is 3841.